Skip to main content

01-03-2019 | Retinopathy | Video | Article

Diabetic retinopathy: Pathogenesis


Speakers: Philip Burgess, John Wilding

Speaker biosDisclosures

Ophthalmologist Philip Burgess joins Clinical Diabetologist John Wilding to discuss the disease processes that lead to retinopathy in people with diabetes (9:11).

Learning points

  • Modifiable versus non-modifiable risk factors of diabetic retinopathy.
  • Current understanding of the pathophysiology of diabetic retinopathy and prospective therapeutic targets.
  • Why rapid improvements in glycemic control may contribute to the pathogenesis of diabetic retinopathy.

More videos in this series


Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »